Amneal Pharmaceuticals

$3.34
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.15 (-4.30%) Today
$0.00 (0.00%) As of 4:02 PM EDT after-hours

Why Robinhood?

You can buy or sell AMRX and other stocks, options, ETFs, and crypto commission-free!

About AMRX

Amneal Pharmaceuticals, Inc. Class A Common Stock, also called Amneal Pharmaceuticals, is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. Read More It operates through the Generics and Specialty segments. The Generics segment develops, manufactures and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products and transdermals. The Specialty segment provides proprietary medicines to the U.S. market. The company was founded by Chintu Patel and Chirag Patel in 2002 and is headquartered in Bridgewater, NJ.

Employees
6,000
Headquarters
Bridgewater, New Jersey
Founded
2002
Market Cap
447.25M
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
2.55M
High Today
$3.49
Low Today
$3.33
Open Price
$3.47
Volume
1.87M
52 Week High
$24.35
52 Week Low
$2.27

Collections

AMRX Earnings

$0.09
$0.17
$0.25
$0.33
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
Actual
Available Nov 6, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.